HEADER TRANSFERASE/TRANSFERASE INHIBITOR 09-DEC-15 5F9E TITLE STRUCTURE OF PROTEIN KINASE C THETA WITH COMPOUND 10: 2,2-DIMETHYL-7- TITLE 2 (2-OXIDANYLIDENE-3~{H}-IMIDAZO[4,5-B]PYRIDIN-1-YL)-1-(PHENYLMETHYL)- TITLE 3 3~{H}-QUINAZOLIN-4-ONE COMPND MOL_ID: 1; COMPND 2 MOLECULE: PROTEIN KINASE C THETA TYPE; COMPND 3 CHAIN: A, B; COMPND 4 SYNONYM: NPKC-THETA; COMPND 5 EC: 2.7.11.13; COMPND 6 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 3 ORGANISM_COMMON: HUMAN; SOURCE 4 ORGANISM_TAXID: 9606; SOURCE 5 GENE: PRKCQ, PRKCT; SOURCE 6 EXPRESSION_SYSTEM: UNIDENTIFIED BACULOVIRUS; SOURCE 7 EXPRESSION_SYSTEM_TAXID: 10469 KEYWDS KINASE, INHIBITOR, TRANSFERASE-TRANSFERASE INHIBITOR COMPLEX EXPDTA X-RAY DIFFRACTION AUTHOR M.KLEIN REVDAT 1 11-MAY-16 5F9E 0 JRNL AUTH T.KATOH,T.TAKAI,T.YUKAWA,T.TSUKAMOTO,E.WATANABE,H.MOTOTANI, JRNL AUTH 2 T.ARITA,H.HAYASHI,H.NAKAGAWA,M.G.KLEIN,H.ZOU,B.C.SANG, JRNL AUTH 3 G.SNELL,Y.NAKADA JRNL TITL DISCOVERY AND OPTIMIZATION OF JRNL TITL 2 1,7-DISUBSTITUTED-2,2-DIMETHYL-2,3-DIHYDROQUINAZOLIN-4(1H) JRNL TITL 3 -ONES AS POTENT AND SELECTIVE PKC THETA INHIBITORS. JRNL REF BIOORG.MED.CHEM. V. 24 2466 2016 JRNL REFN ESSN 1464-3391 JRNL PMID 27117263 JRNL DOI 10.1016/J.BMC.2016.04.008 REMARK 2 REMARK 2 RESOLUTION. 2.00 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : REFMAC 5.7.0025 REMARK 3 AUTHORS : MURSHUDOV,VAGIN,DODSON REMARK 3 REMARK 3 REFINEMENT TARGET : MAXIMUM LIKELIHOOD REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 2.00 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 41.80 REMARK 3 DATA CUTOFF (SIGMA(F)) : NULL REMARK 3 COMPLETENESS FOR RANGE (%) : 97.3 REMARK 3 NUMBER OF REFLECTIONS : 54956 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 CROSS-VALIDATION METHOD : THROUGHOUT REMARK 3 FREE R VALUE TEST SET SELECTION : RANDOM REMARK 3 R VALUE (WORKING + TEST SET) : 0.199 REMARK 3 R VALUE (WORKING SET) : 0.197 REMARK 3 FREE R VALUE : 0.233 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 5.100 REMARK 3 FREE R VALUE TEST SET COUNT : 2929 REMARK 3 REMARK 3 FIT IN THE HIGHEST RESOLUTION BIN. REMARK 3 TOTAL NUMBER OF BINS USED : 20 REMARK 3 BIN RESOLUTION RANGE HIGH (A) : 2.00 REMARK 3 BIN RESOLUTION RANGE LOW (A) : 2.05 REMARK 3 REFLECTION IN BIN (WORKING SET) : 3328 REMARK 3 BIN COMPLETENESS (WORKING+TEST) (%) : 82.17 REMARK 3 BIN R VALUE (WORKING SET) : 0.2990 REMARK 3 BIN FREE R VALUE SET COUNT : 192 REMARK 3 BIN FREE R VALUE : 0.3470 REMARK 3 REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT. REMARK 3 PROTEIN ATOMS : 5248 REMARK 3 NUCLEIC ACID ATOMS : 0 REMARK 3 HETEROGEN ATOMS : 60 REMARK 3 SOLVENT ATOMS : 164 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : NULL REMARK 3 MEAN B VALUE (OVERALL, A**2) : 54.73 REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : 2.74000 REMARK 3 B22 (A**2) : -1.84000 REMARK 3 B33 (A**2) : -0.90000 REMARK 3 B12 (A**2) : 0.00000 REMARK 3 B13 (A**2) : 0.00000 REMARK 3 B23 (A**2) : 0.00000 REMARK 3 REMARK 3 ESTIMATED OVERALL COORDINATE ERROR. REMARK 3 ESU BASED ON R VALUE (A): 0.165 REMARK 3 ESU BASED ON FREE R VALUE (A): 0.152 REMARK 3 ESU BASED ON MAXIMUM LIKELIHOOD (A): 0.108 REMARK 3 ESU FOR B VALUES BASED ON MAXIMUM LIKELIHOOD (A**2): 7.979 REMARK 3 REMARK 3 CORRELATION COEFFICIENTS. REMARK 3 CORRELATION COEFFICIENT FO-FC : 0.963 REMARK 3 CORRELATION COEFFICIENT FO-FC FREE : 0.948 REMARK 3 REMARK 3 RMS DEVIATIONS FROM IDEAL VALUES COUNT RMS WEIGHT REMARK 3 BOND LENGTHS REFINED ATOMS (A): 5499 ; 0.009 ; 0.019 REMARK 3 BOND LENGTHS OTHERS (A): 5180 ; 0.001 ; 0.020 REMARK 3 BOND ANGLES REFINED ATOMS (DEGREES): 7417 ; 1.422 ; 1.973 REMARK 3 BOND ANGLES OTHERS (DEGREES): 11958 ; 0.784 ; 3.000 REMARK 3 TORSION ANGLES, PERIOD 1 (DEGREES): 641 ; 6.264 ; 5.000 REMARK 3 TORSION ANGLES, PERIOD 2 (DEGREES): 279 ;34.549 ;24.014 REMARK 3 TORSION ANGLES, PERIOD 3 (DEGREES): 1007 ;16.338 ;15.000 REMARK 3 TORSION ANGLES, PERIOD 4 (DEGREES): 30 ;18.334 ;15.000 REMARK 3 CHIRAL-CENTER RESTRAINTS (A**3): 753 ; 0.090 ; 0.200 REMARK 3 GENERAL PLANES REFINED ATOMS (A): 6122 ; 0.005 ; 0.021 REMARK 3 GENERAL PLANES OTHERS (A): 1324 ; 0.001 ; 0.020 REMARK 3 NON-BONDED CONTACTS REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 NON-BONDED CONTACTS OTHERS (A): NULL ; NULL ; NULL REMARK 3 NON-BONDED TORSION REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 NON-BONDED TORSION OTHERS (A): NULL ; NULL ; NULL REMARK 3 H-BOND (X...Y) REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 H-BOND (X...Y) OTHERS (A): NULL ; NULL ; NULL REMARK 3 POTENTIAL METAL-ION REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 POTENTIAL METAL-ION OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY VDW REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY VDW OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY H-BOND REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY H-BOND OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY METAL-ION REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY METAL-ION OTHERS (A): NULL ; NULL ; NULL REMARK 3 REMARK 3 ISOTROPIC THERMAL FACTOR RESTRAINTS. COUNT RMS WEIGHT REMARK 3 MAIN-CHAIN BOND REFINED ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 MAIN-CHAIN BOND OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 MAIN-CHAIN ANGLE REFINED ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 MAIN-CHAIN ANGLE OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SIDE-CHAIN BOND REFINED ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SIDE-CHAIN BOND OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SIDE-CHAIN ANGLE REFINED ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SIDE-CHAIN ANGLE OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 LONG RANGE B REFINED ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 LONG RANGE B OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 REMARK 3 ANISOTROPIC THERMAL FACTOR RESTRAINTS. COUNT RMS WEIGHT REMARK 3 RIGID-BOND RESTRAINTS (A**2): NULL ; NULL ; NULL REMARK 3 SPHERICITY; FREE ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SPHERICITY; BONDED ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 REMARK 3 NCS RESTRAINTS STATISTICS REMARK 3 NUMBER OF DIFFERENT NCS GROUPS : NULL REMARK 3 REMARK 3 TLS DETAILS REMARK 3 NUMBER OF TLS GROUPS : 2 REMARK 3 REMARK 3 TLS GROUP : 1 REMARK 3 NUMBER OF COMPONENTS GROUP : 2 REMARK 3 COMPONENTS C SSSEQI TO C SSSEQI REMARK 3 RESIDUE RANGE : A 374 A 709 REMARK 3 RESIDUE RANGE : A 1001 A 1001 REMARK 3 ORIGIN FOR THE GROUP (A): 32.6740 74.9240 30.2966 REMARK 3 T TENSOR REMARK 3 T11: 0.1516 T22: 0.0199 REMARK 3 T33: 0.0934 T12: 0.0040 REMARK 3 T13: -0.0064 T23: 0.0192 REMARK 3 L TENSOR REMARK 3 L11: 1.3098 L22: 1.7655 REMARK 3 L33: 1.6686 L12: 0.4868 REMARK 3 L13: -0.1754 L23: -0.0871 REMARK 3 S TENSOR REMARK 3 S11: 0.0537 S12: 0.0250 S13: 0.0296 REMARK 3 S21: -0.1174 S22: -0.0178 S23: 0.1679 REMARK 3 S31: 0.0360 S32: -0.1571 S33: -0.0358 REMARK 3 REMARK 3 TLS GROUP : 2 REMARK 3 NUMBER OF COMPONENTS GROUP : 2 REMARK 3 COMPONENTS C SSSEQI TO C SSSEQI REMARK 3 RESIDUE RANGE : B 375 B 700 REMARK 3 RESIDUE RANGE : B 1001 B 1001 REMARK 3 ORIGIN FOR THE GROUP (A): 29.7446 84.1102 -8.8861 REMARK 3 T TENSOR REMARK 3 T11: 0.2372 T22: 0.3061 REMARK 3 T33: 0.2570 T12: 0.1107 REMARK 3 T13: -0.0996 T23: 0.0356 REMARK 3 L TENSOR REMARK 3 L11: 1.1108 L22: 2.9367 REMARK 3 L33: 2.9342 L12: -0.3965 REMARK 3 L13: 0.4318 L23: -1.0389 REMARK 3 S TENSOR REMARK 3 S11: 0.0503 S12: 0.0362 S13: -0.0588 REMARK 3 S21: 0.0633 S22: -0.1405 S23: -0.4380 REMARK 3 S31: 0.4183 S32: 0.3618 S33: 0.0901 REMARK 3 REMARK 3 BULK SOLVENT MODELLING. REMARK 3 METHOD USED : MASK REMARK 3 PARAMETERS FOR MASK CALCULATION REMARK 3 VDW PROBE RADIUS : 1.20 REMARK 3 ION PROBE RADIUS : 0.80 REMARK 3 SHRINKAGE RADIUS : 0.80 REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: HYDROGENS HAVE BEEN ADDED IN THE RIDING REMARK 3 POSITIONS REMARK 4 REMARK 4 5F9E COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY RCSB ON 11-DEC-15. REMARK 100 THE DEPOSITION ID IS D_1000216138. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 10-JUL-13 REMARK 200 TEMPERATURE (KELVIN) : 100 REMARK 200 PH : NULL REMARK 200 NUMBER OF CRYSTALS USED : NULL REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : ALS REMARK 200 BEAMLINE : 5.0.3 REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 1 REMARK 200 MONOCHROMATOR : NULL REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : CCD REMARK 200 DETECTOR MANUFACTURER : ADSC QUANTUM 315R REMARK 200 INTENSITY-INTEGRATION SOFTWARE : HKL-2000 REMARK 200 DATA SCALING SOFTWARE : HKL-2000 REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 59517 REMARK 200 RESOLUTION RANGE HIGH (A) : 2.000 REMARK 200 RESOLUTION RANGE LOW (A) : 50.000 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : NULL REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 97.4 REMARK 200 DATA REDUNDANCY : 6.900 REMARK 200 R MERGE (I) : NULL REMARK 200 R SYM (I) : NULL REMARK 200 FOR THE DATA SET : 29.5000 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : NULL REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : NULL REMARK 200 COMPLETENESS FOR SHELL (%) : NULL REMARK 200 DATA REDUNDANCY IN SHELL : NULL REMARK 200 R MERGE FOR SHELL (I) : NULL REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 FOR SHELL : NULL REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT REMARK 200 SOFTWARE USED: PHASER REMARK 200 STARTING MODEL: NULL REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 52.12 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.57 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: 0.1M HEPES PH 7, 0.2M LITHIUM CITRATE, REMARK 280 AND 18% PEG M.W. 3,350, 1% HEXANEDIOL, VAPOR DIFFUSION, HANGING REMARK 280 DROP, TEMPERATURE 290K REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 21 21 21 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X+1/2,-Y,Z+1/2 REMARK 290 3555 -X,Y+1/2,-Z+1/2 REMARK 290 4555 X+1/2,-Y+1/2,-Z REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 37.80150 REMARK 290 SMTRY2 2 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY3 2 0.000000 0.000000 1.000000 74.65200 REMARK 290 SMTRY1 3 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 3 0.000000 1.000000 0.000000 38.39300 REMARK 290 SMTRY3 3 0.000000 0.000000 -1.000000 74.65200 REMARK 290 SMTRY1 4 1.000000 0.000000 0.000000 37.80150 REMARK 290 SMTRY2 4 0.000000 -1.000000 0.000000 38.39300 REMARK 290 SMTRY3 4 0.000000 0.000000 -1.000000 0.00000 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1, 2 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: MONOMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 APPLY THE FOLLOWING TO CHAINS: A REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 350 REMARK 350 BIOMOLECULE: 2 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: MONOMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 APPLY THE FOLLOWING TO CHAINS: B REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 MET A 360 REMARK 465 GLU A 361 REMARK 465 PRO A 362 REMARK 465 GLU A 363 REMARK 465 LEU A 364 REMARK 465 ASN A 365 REMARK 465 LYS A 366 REMARK 465 GLU A 367 REMARK 465 ARG A 368 REMARK 465 PRO A 369 REMARK 465 SER A 370 REMARK 465 LEU A 371 REMARK 465 GLN A 372 REMARK 465 ILE A 373 REMARK 465 HIS A 710 REMARK 465 HIS A 711 REMARK 465 HIS A 712 REMARK 465 MET B 360 REMARK 465 GLU B 361 REMARK 465 PRO B 362 REMARK 465 GLU B 363 REMARK 465 LEU B 364 REMARK 465 ASN B 365 REMARK 465 LYS B 366 REMARK 465 GLU B 367 REMARK 465 ARG B 368 REMARK 465 PRO B 369 REMARK 465 SER B 370 REMARK 465 LEU B 371 REMARK 465 GLN B 372 REMARK 465 ILE B 373 REMARK 465 LYS B 374 REMARK 465 SER B 657 REMARK 465 PRO B 658 REMARK 465 PHE B 659 REMARK 465 ASP B 660 REMARK 465 CYS B 661 REMARK 465 SER B 662 REMARK 465 ASN B 663 REMARK 465 PHE B 664 REMARK 465 ASP B 665 REMARK 465 LYS B 666 REMARK 465 GLU B 667 REMARK 465 PHE B 668 REMARK 465 LEU B 669 REMARK 465 ASN B 670 REMARK 465 GLU B 671 REMARK 465 LYS B 672 REMARK 465 PRO B 673 REMARK 465 ARG B 674 REMARK 465 LEU B 675 REMARK 465 SEP B 676 REMARK 465 PHE B 677 REMARK 465 ALA B 678 REMARK 465 ASP B 679 REMARK 465 ARG B 680 REMARK 465 ALA B 681 REMARK 465 LEU B 682 REMARK 465 ILE B 683 REMARK 465 ASN B 684 REMARK 465 SER B 685 REMARK 465 MET B 686 REMARK 465 ASP B 687 REMARK 465 GLN B 688 REMARK 465 MET B 701 REMARK 465 GLU B 702 REMARK 465 ARG B 703 REMARK 465 LEU B 704 REMARK 465 ILE B 705 REMARK 465 SER B 706 REMARK 465 HIS B 707 REMARK 465 HIS B 708 REMARK 465 HIS B 709 REMARK 465 HIS B 710 REMARK 465 HIS B 711 REMARK 465 HIS B 712 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 LYS A 400 -133.99 42.42 REMARK 500 THR A 402 166.01 -48.69 REMARK 500 ASN A 403 30.86 -90.86 REMARK 500 HIS A 474 -46.17 74.61 REMARK 500 ARG A 503 -5.11 73.24 REMARK 500 ASP A 522 90.67 72.18 REMARK 500 ASN A 537 17.26 -140.77 REMARK 500 ASN A 557 -150.69 -125.13 REMARK 500 PHE A 614 45.15 -89.66 REMARK 500 ASN A 689 -19.58 -45.03 REMARK 500 LYS B 400 -57.58 78.79 REMARK 500 LYS B 401 -79.60 -66.56 REMARK 500 HIS B 474 -55.55 70.97 REMARK 500 ARG B 503 -7.56 71.76 REMARK 500 ASP B 522 88.94 62.54 REMARK 500 ASN B 537 21.83 -145.44 REMARK 500 CYS B 540 135.47 -170.19 REMARK 500 ASN B 557 -153.91 -123.77 REMARK 500 PHE B 614 39.31 -81.90 REMARK 500 MET B 690 33.94 -86.26 REMARK 500 PHE B 691 42.11 -106.77 REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: NON-CIS, NON-TRANS REMARK 500 REMARK 500 THE FOLLOWING PEPTIDE BONDS DEVIATE SIGNIFICANTLY FROM BOTH REMARK 500 CIS AND TRANS CONFORMATION. CIS BONDS, IF ANY, ARE LISTED REMARK 500 ON CISPEP RECORDS. TRANS IS DEFINED AS 180 +/- 30 AND REMARK 500 CIS IS DEFINED AS 0 +/- 30 DEGREES. REMARK 500 MODEL OMEGA REMARK 500 PHE B 539 CYS B 540 -147.91 REMARK 500 REMARK 500 REMARK: NULL REMARK 800 REMARK 800 SITE REMARK 800 SITE_IDENTIFIER: AC1 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue 5VS A 1001 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC2 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue 5VS B 1001 DBREF 5F9E A 361 706 UNP Q04759 KPCT_HUMAN 361 706 DBREF 5F9E B 361 706 UNP Q04759 KPCT_HUMAN 361 706 SEQADV 5F9E MET A 360 UNP Q04759 INITIATING METHIONINE SEQADV 5F9E GLU A 381 UNP Q04759 ILE 381 CONFLICT SEQADV 5F9E GLU A 538 UNP Q04759 THR 538 CONFLICT SEQADV 5F9E HIS A 707 UNP Q04759 EXPRESSION TAG SEQADV 5F9E HIS A 708 UNP Q04759 EXPRESSION TAG SEQADV 5F9E HIS A 709 UNP Q04759 EXPRESSION TAG SEQADV 5F9E HIS A 710 UNP Q04759 EXPRESSION TAG SEQADV 5F9E HIS A 711 UNP Q04759 EXPRESSION TAG SEQADV 5F9E HIS A 712 UNP Q04759 EXPRESSION TAG SEQADV 5F9E MET B 360 UNP Q04759 INITIATING METHIONINE SEQADV 5F9E GLU B 381 UNP Q04759 ILE 381 CONFLICT SEQADV 5F9E GLU B 538 UNP Q04759 THR 538 CONFLICT SEQADV 5F9E HIS B 707 UNP Q04759 EXPRESSION TAG SEQADV 5F9E HIS B 708 UNP Q04759 EXPRESSION TAG SEQADV 5F9E HIS B 709 UNP Q04759 EXPRESSION TAG SEQADV 5F9E HIS B 710 UNP Q04759 EXPRESSION TAG SEQADV 5F9E HIS B 711 UNP Q04759 EXPRESSION TAG SEQADV 5F9E HIS B 712 UNP Q04759 EXPRESSION TAG SEQRES 1 A 353 MET GLU PRO GLU LEU ASN LYS GLU ARG PRO SER LEU GLN SEQRES 2 A 353 ILE LYS LEU LYS ILE GLU ASP PHE GLU LEU HIS LYS MET SEQRES 3 A 353 LEU GLY LYS GLY SER PHE GLY LYS VAL PHE LEU ALA GLU SEQRES 4 A 353 PHE LYS LYS THR ASN GLN PHE PHE ALA ILE LYS ALA LEU SEQRES 5 A 353 LYS LYS ASP VAL VAL LEU MET ASP ASP ASP VAL GLU CYS SEQRES 6 A 353 THR MET VAL GLU LYS ARG VAL LEU SER LEU ALA TRP GLU SEQRES 7 A 353 HIS PRO PHE LEU THR HIS MET PHE CYS THR PHE GLN THR SEQRES 8 A 353 LYS GLU ASN LEU PHE PHE VAL MET GLU TYR LEU ASN GLY SEQRES 9 A 353 GLY ASP LEU MET TYR HIS ILE GLN SER CYS HIS LYS PHE SEQRES 10 A 353 ASP LEU SER ARG ALA THR PHE TYR ALA ALA GLU ILE ILE SEQRES 11 A 353 LEU GLY LEU GLN PHE LEU HIS SER LYS GLY ILE VAL TYR SEQRES 12 A 353 ARG ASP LEU LYS LEU ASP ASN ILE LEU LEU ASP LYS ASP SEQRES 13 A 353 GLY HIS ILE LYS ILE ALA ASP PHE GLY MET CYS LYS GLU SEQRES 14 A 353 ASN MET LEU GLY ASP ALA LYS THR ASN GLU PHE CYS GLY SEQRES 15 A 353 THR PRO ASP TYR ILE ALA PRO GLU ILE LEU LEU GLY GLN SEQRES 16 A 353 LYS TYR ASN HIS SER VAL ASP TRP TRP SER PHE GLY VAL SEQRES 17 A 353 LEU LEU TYR GLU MET LEU ILE GLY GLN SER PRO PHE HIS SEQRES 18 A 353 GLY GLN ASP GLU GLU GLU LEU PHE HIS SER ILE ARG MET SEQRES 19 A 353 ASP ASN PRO PHE TYR PRO ARG TRP LEU GLU LYS GLU ALA SEQRES 20 A 353 LYS ASP LEU LEU VAL LYS LEU PHE VAL ARG GLU PRO GLU SEQRES 21 A 353 LYS ARG LEU GLY VAL ARG GLY ASP ILE ARG GLN HIS PRO SEQRES 22 A 353 LEU PHE ARG GLU ILE ASN TRP GLU GLU LEU GLU ARG LYS SEQRES 23 A 353 GLU ILE ASP PRO PRO PHE ARG PRO LYS VAL LYS SER PRO SEQRES 24 A 353 PHE ASP CYS SER ASN PHE ASP LYS GLU PHE LEU ASN GLU SEQRES 25 A 353 LYS PRO ARG LEU SEP PHE ALA ASP ARG ALA LEU ILE ASN SEQRES 26 A 353 SER MET ASP GLN ASN MET PHE ARG ASN PHE SEP PHE MET SEQRES 27 A 353 ASN PRO GLY MET GLU ARG LEU ILE SER HIS HIS HIS HIS SEQRES 28 A 353 HIS HIS SEQRES 1 B 353 MET GLU PRO GLU LEU ASN LYS GLU ARG PRO SER LEU GLN SEQRES 2 B 353 ILE LYS LEU LYS ILE GLU ASP PHE GLU LEU HIS LYS MET SEQRES 3 B 353 LEU GLY LYS GLY SER PHE GLY LYS VAL PHE LEU ALA GLU SEQRES 4 B 353 PHE LYS LYS THR ASN GLN PHE PHE ALA ILE LYS ALA LEU SEQRES 5 B 353 LYS LYS ASP VAL VAL LEU MET ASP ASP ASP VAL GLU CYS SEQRES 6 B 353 THR MET VAL GLU LYS ARG VAL LEU SER LEU ALA TRP GLU SEQRES 7 B 353 HIS PRO PHE LEU THR HIS MET PHE CYS THR PHE GLN THR SEQRES 8 B 353 LYS GLU ASN LEU PHE PHE VAL MET GLU TYR LEU ASN GLY SEQRES 9 B 353 GLY ASP LEU MET TYR HIS ILE GLN SER CYS HIS LYS PHE SEQRES 10 B 353 ASP LEU SER ARG ALA THR PHE TYR ALA ALA GLU ILE ILE SEQRES 11 B 353 LEU GLY LEU GLN PHE LEU HIS SER LYS GLY ILE VAL TYR SEQRES 12 B 353 ARG ASP LEU LYS LEU ASP ASN ILE LEU LEU ASP LYS ASP SEQRES 13 B 353 GLY HIS ILE LYS ILE ALA ASP PHE GLY MET CYS LYS GLU SEQRES 14 B 353 ASN MET LEU GLY ASP ALA LYS THR ASN GLU PHE CYS GLY SEQRES 15 B 353 THR PRO ASP TYR ILE ALA PRO GLU ILE LEU LEU GLY GLN SEQRES 16 B 353 LYS TYR ASN HIS SER VAL ASP TRP TRP SER PHE GLY VAL SEQRES 17 B 353 LEU LEU TYR GLU MET LEU ILE GLY GLN SER PRO PHE HIS SEQRES 18 B 353 GLY GLN ASP GLU GLU GLU LEU PHE HIS SER ILE ARG MET SEQRES 19 B 353 ASP ASN PRO PHE TYR PRO ARG TRP LEU GLU LYS GLU ALA SEQRES 20 B 353 LYS ASP LEU LEU VAL LYS LEU PHE VAL ARG GLU PRO GLU SEQRES 21 B 353 LYS ARG LEU GLY VAL ARG GLY ASP ILE ARG GLN HIS PRO SEQRES 22 B 353 LEU PHE ARG GLU ILE ASN TRP GLU GLU LEU GLU ARG LYS SEQRES 23 B 353 GLU ILE ASP PRO PRO PHE ARG PRO LYS VAL LYS SER PRO SEQRES 24 B 353 PHE ASP CYS SER ASN PHE ASP LYS GLU PHE LEU ASN GLU SEQRES 25 B 353 LYS PRO ARG LEU SEP PHE ALA ASP ARG ALA LEU ILE ASN SEQRES 26 B 353 SER MET ASP GLN ASN MET PHE ARG ASN PHE SEP PHE MET SEQRES 27 B 353 ASN PRO GLY MET GLU ARG LEU ILE SER HIS HIS HIS HIS SEQRES 28 B 353 HIS HIS MODRES 5F9E SEP A 676 SER MODIFIED RESIDUE MODRES 5F9E SEP A 695 SER MODIFIED RESIDUE MODRES 5F9E SEP B 695 SER MODIFIED RESIDUE HET SEP A 676 10 HET SEP A 695 10 HET SEP B 695 10 HET 5VS A1001 30 HET 5VS B1001 30 HETNAM SEP PHOSPHOSERINE HETNAM 5VS 2,2-DIMETHYL-7-(2-OXIDANYLIDENE-3~{H}-IMIDAZO[4,5- HETNAM 2 5VS B]PYRIDIN-1-YL)-1-(PHENYLMETHYL)-3~{H}-QUINAZOLIN-4- HETNAM 3 5VS ONE HETSYN SEP PHOSPHONOSERINE FORMUL 1 SEP 3(C3 H8 N O6 P) FORMUL 3 5VS 2(C23 H21 N5 O2) FORMUL 5 HOH *164(H2 O) HELIX 1 AA1 LYS A 376 GLU A 378 5 3 HELIX 2 AA2 LYS A 413 ASP A 419 1 7 HELIX 3 AA3 ASP A 421 TRP A 436 1 16 HELIX 4 AA4 LEU A 466 HIS A 474 1 9 HELIX 5 AA5 ASP A 477 LYS A 498 1 22 HELIX 6 AA6 LYS A 506 ASP A 508 5 3 HELIX 7 AA7 THR A 542 ILE A 546 5 5 HELIX 8 AA8 ALA A 547 LEU A 552 1 6 HELIX 9 AA9 HIS A 558 GLY A 575 1 18 HELIX 10 AB1 ASP A 583 ASP A 594 1 12 HELIX 11 AB2 GLU A 603 PHE A 614 1 12 HELIX 12 AB3 GLU A 617 ARG A 621 5 5 HELIX 13 AB4 ASP A 627 ARG A 635 5 9 HELIX 14 AB5 ASN A 638 ARG A 644 1 7 HELIX 15 AB6 ASP A 665 ASN A 670 1 6 HELIX 16 AB7 ASP A 679 MET A 686 1 8 HELIX 17 AB8 ASP A 687 ARG A 692 5 6 HELIX 18 AB9 ASN A 698 HIS A 708 1 11 HELIX 19 AC1 LYS B 376 PHE B 380 5 5 HELIX 20 AC2 LYS B 413 ASP B 419 1 7 HELIX 21 AC3 ASP B 421 TRP B 436 1 16 HELIX 22 AC4 ASP B 465 HIS B 474 1 10 HELIX 23 AC5 ASP B 477 LYS B 498 1 22 HELIX 24 AC6 LYS B 506 ASP B 508 5 3 HELIX 25 AC7 THR B 542 ILE B 546 5 5 HELIX 26 AC8 ALA B 547 LEU B 552 1 6 HELIX 27 AC9 HIS B 558 GLY B 575 1 18 HELIX 28 AD1 ASP B 583 ASP B 594 1 12 HELIX 29 AD2 GLU B 603 PHE B 614 1 12 HELIX 30 AD3 GLU B 617 ARG B 621 5 5 HELIX 31 AD4 ASP B 627 ARG B 635 5 9 HELIX 32 AD5 ASN B 638 ARG B 644 1 7 SHEET 1 AA1 6 PHE A 380 GLY A 389 0 SHEET 2 AA1 6 GLY A 392 PHE A 399 -1 O VAL A 394 N GLY A 387 SHEET 3 AA1 6 PHE A 405 LYS A 412 -1 O ALA A 410 N LYS A 393 SHEET 4 AA1 6 ASN A 453 GLU A 459 -1 O MET A 458 N ALA A 407 SHEET 5 AA1 6 MET A 444 GLN A 449 -1 N CYS A 446 O VAL A 457 SHEET 6 AA1 6 PHE A 696 MET A 697 -1 O PHE A 696 N THR A 447 SHEET 1 AA2 3 GLY A 464 ASP A 465 0 SHEET 2 AA2 3 ILE A 510 LEU A 512 -1 O LEU A 512 N GLY A 464 SHEET 3 AA2 3 ILE A 518 ILE A 520 -1 O LYS A 519 N LEU A 511 SHEET 1 AA3 6 GLU B 381 GLY B 389 0 SHEET 2 AA3 6 GLY B 392 GLU B 398 -1 O LEU B 396 N HIS B 383 SHEET 3 AA3 6 PHE B 405 LYS B 412 -1 O ALA B 410 N LYS B 393 SHEET 4 AA3 6 ASN B 453 MET B 458 -1 O MET B 458 N ALA B 407 SHEET 5 AA3 6 MET B 444 GLN B 449 -1 N CYS B 446 O VAL B 457 SHEET 6 AA3 6 PHE B 696 MET B 697 -1 O PHE B 696 N THR B 447 SHEET 1 AA4 2 ILE B 510 LEU B 512 0 SHEET 2 AA4 2 ILE B 518 ILE B 520 -1 O LYS B 519 N LEU B 511 LINK C LEU A 675 N SEP A 676 1555 1555 1.32 LINK C SEP A 676 N PHE A 677 1555 1555 1.32 LINK C PHE A 694 N SEP A 695 1555 1555 1.33 LINK C SEP A 695 N PHE A 696 1555 1555 1.32 LINK C PHE B 694 N SEP B 695 1555 1555 1.33 LINK C SEP B 695 N PHE B 696 1555 1555 1.33 SITE 1 AC1 14 LEU A 386 GLY A 387 PHE A 391 VAL A 394 SITE 2 AC1 14 ALA A 407 LYS A 409 THR A 442 MET A 458 SITE 3 AC1 14 GLU A 459 LEU A 461 ASN A 509 LEU A 511 SITE 4 AC1 14 ASP A 522 PHE A 664 SITE 1 AC2 9 LEU B 386 PHE B 391 ALA B 407 LYS B 409 SITE 2 AC2 9 THR B 442 MET B 458 GLU B 459 LEU B 461 SITE 3 AC2 9 ASN B 509 CRYST1 75.603 76.786 149.304 90.00 90.00 90.00 P 21 21 21 8 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.013227 0.000000 0.000000 0.00000 SCALE2 0.000000 0.013023 0.000000 0.00000 SCALE3 0.000000 0.000000 0.006698 0.00000